https://tissuepathology.com Educational and informative Thu, 11 Jun 2026 18:00:28 +0000 en-US hourly 1 https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png https://tissuepathology.com 32 32 https://tissuepathology.com/2026/06/11/asco-now-and-then/ Thu, 11 Jun 2026 18:00:28 +0000 https://tissuepathology.com/?p=24484 In medical school I drove a cab at night to make ends meet. I rented the medallion from a guy for $50 and kept the difference I made. The Army paid me $692 a month stipend on the Health Professions Scholarship and the studio apartment in downtown Chicago was $1000/month. I wasshort over $300 a […]

The post ASCO: Now and Then first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/06/10/photocure-and-artera-to-partner-on-digital-pathology-ai-test-evaluation-for-bladder-cancer/ Wed, 10 Jun 2026 12:08:44 +0000 https://tissuepathology.com/?p=24479 OSLO, Norway, June 8, 2026 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative. The collaboration encompasses Photocure’s blue light cystoscopy (BLC®) registry in bladder cancer and the ArteraAI Bladder Test, an AI-powered digital pathology test currently in development for patients with bladder cancer. […]

The post Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/06/09/aignostics-partners-with-the-pancreatic-cancer-action-network-to-advance-pancreatic-cancer-research/ Tue, 09 Jun 2026 13:28:40 +0000 https://tissuepathology.com/?p=24476 Collaboration will apply Aignostics AI-technology to PanCAN’s multimodal pancreatic cancer dataset, with results made broadly accessible to both academic and life sciences researchers. LOS ANGELES and BERLIN and NEW YORK, June 9, 2026 /PRNewswire/ — Today, Aignostics announced a new partnership with the Pancreatic Cancer Action Network (PanCAN) to generate and share spatial profiling readouts for one of […]

The post Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/06/03/proscia-nextgen-pathology-selects-proscia-to-establish-ai-foundation-for-business-growth/ Wed, 03 Jun 2026 13:49:31 +0000 https://tissuepathology.com/?p=24462 Proscia: National group positions itself as key partner for biopharmaceutical research, strengthening its role in precision medicine MELBOURNE, FL and PHILADELPHIA — June 3, 2026 — NextGen Pathology, a national group of general and consultant pathologists, has chosen Proscia® to drive its next phase of business growth. By adopting the Concentriq® platform, the group will lay an AI foundation for […]

The post Proscia: NextGen Pathology Selects Proscia to Establish AI Foundation for Business Growth first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/05/28/diadeep-and-leica-biosystems-partner-to-bring-ai-oncology-pathology-applications-to-the-aperio-ai-store/ Thu, 28 May 2026 14:29:19 +0000 https://tissuepathology.com/?p=24450 DiaDeep and Leica Biosystems: Expanding access to integrated AI tools helps pathologists tackle complex workflows and improve insights Lyon, France and VISTA, CA — May 27, 2026  DiaDeep, a Lyon-based company specialized in medical AI for oncology pathology, and Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, today […]

The post DiaDeep and Leica Biosystems Partner to Bring AI Oncology Pathology Applications to the Aperio AI Store first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/05/27/industry-leaders-leica-biosystems-indica-labs-and-lunit-partner-to-develop-ai-powered-computational-pathology-assays-for-pd-l1-and-emerging-biomarkers/ Wed, 27 May 2026 12:04:00 +0000 https://tissuepathology.com/?p=24442 VISTA, California, ALBUQUERQUE, New Mexico, and SEOUL, South Korea — May 26, 2026 — Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, and Indica Labs, a global leader in AI-powered digital pathology software, today announced a strategic collaboration with Lunit (KRX:328130.KQ), a leading provider of AI solutions for cancer diagnostics […]

The post Industry Leaders Leica Biosystems, Indica Labs and Lunit Partner to Develop AI-Powered Computational Pathology Assays for PD-L1 and Emerging Biomarkers first appeared on Tissuepathology.com.]]>